Drug Shortage Report for FASTURTEC

Last updated on 2017-08-17 History
Report ID 16581
Drug Identification Number 02248416
Brand name FASTURTEC
Common or Proper name Fasturtec 1.5mg vial powder plus 1.0mL solvent
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RASBURICASE
Strength(s) 1.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 3 vials
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-07-17
Estimated end date 2017-09-04
Actual end date 2017-08-16
Shortage status Resolved
Updated date 2017-08-17
Company comments RESOLVED/RELEASED 2017-08-16
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-08-17 English Compare
v4 2017-08-16 French Compare
v3 2017-08-16 English Compare
v2 2017-07-21 French Compare
v1 2017-07-21 English Compare